ciprofloxacin has been researched along with Injuries in 17 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to compare the efficacy of single-dose intravenous cefazolin prophylaxis with single-dose oral ciprofloxacin prophylaxis in patients undergoing tension-free inguinal hernia repair with polypropylene mesh." | 9.11 | Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study. ( Ergör, G; Füzün, M; Hoşgörler, F; Kiliç, D; Terzi, C; Unek, T, 2005) |
| "The aim of this study was to compare the efficacy of single-dose intravenous cefazolin prophylaxis with single-dose oral ciprofloxacin prophylaxis in patients undergoing tension-free inguinal hernia repair with polypropylene mesh." | 5.11 | Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study. ( Ergör, G; Füzün, M; Hoşgörler, F; Kiliç, D; Terzi, C; Unek, T, 2005) |
| "Ionizing radiation exposure combined with wound injury increases animal mortalities than ionizing radiation exposure alone." | 1.42 | Ciprofloxacin Therapy Results in Mitigation of ATP Loss after Irradiation Combined with Wound Trauma: Preservation of Pyruvate Dehydrogenase and Inhibition of Pyruvate Dehydrogenase Kinase 1. ( Kiang, JG; Smith, JT; Swift, JM, 2015) |
| "Radiation combined injury (CI) is a radiation injury (RI) combined with other types of injury, which generally leads to greater mortality than RI alone." | 1.39 | Ciprofloxacin modulates cytokine/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound trauma. ( Cary, LH; Elliott, TB; Fukumoto, R; Gorbunov, NV; Kiang, JG; Lombardini, ED, 2013) |
| "To determine the pharmacokinetic parameters of cefpirome, a new so-called fourth-generation cephalosporin, in previously healthy trauma patients with posttraumatic systemic inflammatory response syndrome (SIRS) and to compare them to parameters obtained in matched, healthy volunteers." | 1.30 | Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome. ( Edouard, AR; Incagnoli, P; Jacolot, A; Mimoz, O; Petitjean, O; Samii, K; Tod, M, 1999) |
| "Amikacin and imipenem were the agents most active against the 33,869 nonduplicate isolates (those recovered only once) tested." | 1.29 | Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. ( Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA, 1996) |
| " The dosage studied appeared to provide adequate serum concentration profiles to treat most pathogens found in infected trauma patients." | 1.28 | Ciprofloxacin pharmacokinetics in critically ill trauma patients. ( Caplan, ES; Drusano, GL; Forrest, A; Plaisance, K; Yuen, GJ, 1989) |
| "We examined the use of optimal sampling theory to determine a sparse sampling design to estimate pharmacokinetic parameters of ciprofloxacin in patients who had sustained trauma." | 1.28 | Prospective use of optimal sampling theory: steady-state ciprofloxacin pharmacokinetics in critically ill trauma patients. ( Caplan, ES; Drusano, GL; Forrest, A; Plaisance, K; Yuen, GJ, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contardi, M | 1 |
| Heredia-Guerrero, JA | 1 |
| Perotto, G | 1 |
| Valentini, P | 1 |
| Pompa, PP | 1 |
| Spanò, R | 1 |
| Goldoni, L | 1 |
| Bertorelli, R | 1 |
| Athanassiou, A | 1 |
| Bayer, IS | 1 |
| Hassanzadeh, S | 1 |
| Mashhadi, R | 1 |
| Yousefi, M | 1 |
| Askari, E | 1 |
| Saniei, M | 1 |
| Pourmand, MR | 1 |
| Fukumoto, R | 1 |
| Cary, LH | 1 |
| Gorbunov, NV | 1 |
| Lombardini, ED | 1 |
| Elliott, TB | 1 |
| Kiang, JG | 2 |
| Kevadiya, BD | 1 |
| Rajkumar, S | 1 |
| Bajaj, HC | 1 |
| Chettiar, SS | 1 |
| Gosai, K | 1 |
| Brahmbhatt, H | 1 |
| Bhatt, AS | 1 |
| Barvaliya, YK | 1 |
| Dave, GS | 1 |
| Kothari, RK | 1 |
| Swift, JM | 1 |
| Smith, JT | 1 |
| Li, H | 1 |
| Williams, GR | 1 |
| Wu, J | 1 |
| Lv, Y | 1 |
| Sun, X | 1 |
| Wu, H | 1 |
| Zhu, LM | 1 |
| Kiamco, MM | 1 |
| Atci, E | 1 |
| Mohamed, A | 1 |
| Call, DR | 1 |
| Beyenal, H | 1 |
| Sekowska, A | 1 |
| Buzała, K | 1 |
| Pluta, J | 1 |
| Gospodarek, E | 1 |
| Blanco, JF | 1 |
| Pescador, D | 1 |
| Martín, JM | 1 |
| Cano, C | 1 |
| Sánchez, MD | 1 |
| Terzi, C | 1 |
| Kiliç, D | 1 |
| Unek, T | 1 |
| Hoşgörler, F | 1 |
| Füzün, M | 1 |
| Ergör, G | 1 |
| Phaneuf, MD | 1 |
| Bide, MJ | 1 |
| Hannel, SL | 1 |
| Platek, MJ | 1 |
| Monahan, TS | 1 |
| Contreras, MA | 1 |
| Phaneuf, TM | 1 |
| LoGerfo, FW | 1 |
| Itokazu, GS | 1 |
| Quinn, JP | 1 |
| Bell-Dixon, C | 1 |
| Kahan, FM | 1 |
| Weinstein, RA | 1 |
| Ivanov, RN | 1 |
| Eltahawy, AT | 1 |
| Jacolot, A | 1 |
| Incagnoli, P | 1 |
| Edouard, AR | 1 |
| Tod, M | 1 |
| Petitjean, O | 1 |
| Samii, K | 1 |
| Mimoz, O | 1 |
| Yuen, GJ | 2 |
| Drusano, GL | 2 |
| Plaisance, K | 2 |
| Forrest, A | 2 |
| Caplan, ES | 2 |
1 trial available for ciprofloxacin and Injuries
| Article | Year |
|---|---|
Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infectio | 2005 |
16 other studies available for ciprofloxacin and Injuries
| Article | Year |
|---|---|
Transparent ciprofloxacin-povidone antibiotic films and nanofiber mats as potential skin and wound care dressings.
Topics: Animals; Anti-Bacterial Agents; Bacillus subtilis; Bandages; Ciprofloxacin; Escherichia coli; Magnet | 2017 |
Frequency of efflux pump genes mediating ciprofloxacin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blood; Ciprofloxacin; DNA, Bacterial; Fluoroquinolones; G | 2017 |
Ciprofloxacin modulates cytokine/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound trauma.
Topics: Animals; Anti-Infective Agents; Apoptosis; Autophagy; Bacterial Infections; Ciprofloxacin; Cytokines | 2013 |
Biodegradable gelatin-ciprofloxacin-montmorillonite composite hydrogels for controlled drug release and wound dressing application.
Topics: Anti-Bacterial Agents; Bandages; Bentonite; Biocompatible Materials; Cell Line, Tumor; Ciprofloxacin | 2014 |
Ciprofloxacin Therapy Results in Mitigation of ATP Loss after Irradiation Combined with Wound Trauma: Preservation of Pyruvate Dehydrogenase and Inhibition of Pyruvate Dehydrogenase Kinase 1.
Topics: Adenosine Triphosphate; Administration, Oral; Animals; Ciprofloxacin; Female; Gamma Rays; HSP70 Heat | 2015 |
Thermosensitive nanofibers loaded with ciprofloxacin as antibacterial wound dressing materials.
Topics: Animals; Anti-Bacterial Agents; Bandages; Ciprofloxacin; Drug Carriers; Drug Liberation; Escherichia | 2017 |
Hyperosmotic Agents and Antibiotics Affect Dissolved Oxygen and pH Concentration Gradients in Staphylococcus aureus Biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Combined Modality Therapy; Honey; Hydrogen-Ion Conce | 2017 |
[Susceptibility of Klebsiella oxytoca to selected antibiotics].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Human | 2011 |
Acute infection of total knee arthroplasty due to a cat scratch in a patient with rheumatoid arthritis.
Topics: Acute Disease; Aged, 80 and over; Animals; Anti-Infective Agents; Arthritis, Infectious; Arthritis, | 2012 |
Development of an infection-resistant, bioactive wound dressing surface.
Topics: Bacterial Infections; Bandages; Biocompatible Materials; Blood Coagulation; Ciprofloxacin; Ethylened | 2005 |
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; | 1996 |
[The use of Ciprobay in the infectious complications of traumatic illness].
Topics: Anti-Infective Agents; Ciprofloxacin; Communicable Diseases; Humans; Wounds and Injuries | 1997 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciproflo | 1997 |
Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome.
Topics: Adult; Anti-Infective Agents; Case-Control Studies; Cefpirome; Cephalosporins; Ciprofloxacin; Drug T | 1999 |
Ciprofloxacin pharmacokinetics in critically ill trauma patients.
Topics: Adult; Aged; Ciprofloxacin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Wounds and | 1989 |
Prospective use of optimal sampling theory: steady-state ciprofloxacin pharmacokinetics in critically ill trauma patients.
Topics: Adult; Aged; Bayes Theorem; Ciprofloxacin; Critical Care; Female; Humans; Infusions, Intravenous; Ki | 1989 |